An audience with... Gregory Lip. Interview by Asher Mullard.
Gregory
G
Lip
D000925:Anticoagulants / Q000494:pharmacology* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D000069604:Dabigatran; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D012042:Registries; D014481:United States; D014486:United States Food and Drug Administration; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran